Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy
- PMID: 18329345
- DOI: 10.1016/j.dnarep.2008.01.014
Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy
Abstract
Laboratory diagnosis for DNA repair diseases has been performed in western Europe from the early seventies for xeroderma pigmentosum (XP) and from the mid-eighties for Cockayne syndrome (CS) and trichothiodystrophy (TTD). The combined data from the DNA repair diagnostic centres in France, (West) Germany, Italy, the Netherlands and the United Kingdom have been investigated for three groups of diseases: XP (including XP-variant), CS (including XP/CS complex) and TTD. Incidences in western Europe were for the first time established at 2.3 per million livebirths for XP, 2.7 per million for CS and 1.2 per million for TTD. As immigrant populations were disproportionately represented in the patients' groups, incidences were also established for the autochthonic western European population at: 0.9 per million for XP, 1.8 per million for CS and 1.1 per million for TTD. Perhaps contrary to general conceptions, compared to XP the incidence of CS appears to be somewhat higher and the incidence of TTD to be quite similar in the native West-European population.
Similar articles
-
Comparative study of nucleotide excision repair defects between XPD-mutated fibroblasts derived from trichothiodystrophy and xeroderma pigmentosum patients.DNA Repair (Amst). 2008 Dec 1;7(12):1990-8. doi: 10.1016/j.dnarep.2008.08.009. Epub 2008 Oct 10. DNA Repair (Amst). 2008. PMID: 18817897
-
The cancer-free phenotype in trichothiodystrophy is unrelated to its repair defect.Cancer Res. 2000 Jan 15;60(2):431-8. Cancer Res. 2000. PMID: 10667598
-
Functional and molecular genetic analyses of nine newly identified XPD-deficient patients reveal a novel mutation resulting in TTD as well as in XP/CS complex phenotypes.Exp Dermatol. 2013 Jul;22(7):486-9. doi: 10.1111/exd.12166. Exp Dermatol. 2013. PMID: 23800062
-
Xeroderma pigmentosum-Cockayne syndrome complex.Orphanet J Rare Dis. 2017 Apr 4;12(1):65. doi: 10.1186/s13023-017-0616-2. Orphanet J Rare Dis. 2017. PMID: 28376890 Free PMC article. Review.
-
A summary of mutations in the UV-sensitive disorders: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy.Hum Mutat. 1999;14(1):9-22. doi: 10.1002/(SICI)1098-1004(1999)14:1<9::AID-HUMU2>3.0.CO;2-6. Hum Mutat. 1999. PMID: 10447254 Review.
Cited by
-
Ending a diagnostic odyssey: Moving from exome to genome to identify cockayne syndrome.Mol Genet Genomic Med. 2021 Jul;9(7):e1623. doi: 10.1002/mgg3.1623. Epub 2021 Jun 2. Mol Genet Genomic Med. 2021. PMID: 34076366 Free PMC article.
-
The cerebro-morphological fingerprint of a progeroid syndrome: white matter changes correlate with neurological symptoms in xeroderma pigmentosum.PLoS One. 2012;7(2):e30926. doi: 10.1371/journal.pone.0030926. Epub 2012 Feb 21. PLoS One. 2012. PMID: 22363517 Free PMC article.
-
Abnormal XPD-induced nuclear receptor transactivation in DNA repair disorders: trichothiodystrophy and xeroderma pigmentosum.Eur J Hum Genet. 2013 Aug;21(8):831-7. doi: 10.1038/ejhg.2012.246. Epub 2012 Dec 12. Eur J Hum Genet. 2013. PMID: 23232694 Free PMC article.
-
Neurological disease in xeroderma pigmentosum: prospective cohort study of its features and progression.Brain. 2023 Dec 1;146(12):5044-5059. doi: 10.1093/brain/awad266. Brain. 2023. PMID: 38040034 Free PMC article.
-
Hemochromatosis and Xeroderma Pigmentosum: Two (Un)Suspicious Neighbors.GE Port J Gastroenterol. 2021 Feb 5;29(1):38-44. doi: 10.1159/000513587. eCollection 2022 Jan. GE Port J Gastroenterol. 2021. PMID: 35111962 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials